ATryn from milk of goats approved to treat hereditary antithrombin deficiency
The U.S. Food and Drug Administration FDA Approves Orphan Drug ATryn to Treat Rare Clotting Disorder – The U.S. Food and Drug Administration issued its first approval for a biological product produced by genetically engineered (GE) animals.